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ABSTRACT
The proteome-wide characterization and analysis of
protein ligand-binding sites and their interactions
with ligands can provide pivotal information in understanding the structure, function and evolution of
proteins and for designing safe and efficient therapeutics. The SMAP web service (SMAP-WS) meets
this need through parallel computations designed
for 3D ligand-binding site comparison and similarity
searching on a structural proteome scale. SMAP-WS
implements a shape descriptor (the Geometric
Potential) that characterizes both local and global
topological properties of the protein structure and
which can be used to predict the likely ligand-binding
pocket [Xie,L. and Bourne,P.E. (2007) A robust and
efficient algorithm for the shape description of
protein structures and its application in predicting
ligand-binding sites. BMC bioinformatics, 8 (Suppl.
4.), S9.]. Subsequently a sequence order independent
profile–profile alignment (SOIPPA) algorithm is used
to detect and align similar pockets thereby finding
protein functional and evolutionary relationships
across fold space [Xie, L. and Bourne, P.E. (2008)
Detecting evolutionary relationships across existing
fold space, using sequence order-independent
profile-profile alignments. Proc. Natl Acad. Sci.
USA, 105, 5441–5446]. An extreme value distribution
model estimates the statistical significance of the
match [Xie, L., Xie, L. and Bourne, P.E. (2009) A
unified statistical model to support local sequence
order independent similarity searching for
ligand-binding sites and its application to
genome-based drug discovery. Bioinformatics, 25,
i305–i312.]. These algorithms have been extensively
benchmarked and shown to outperform most

existing algorithms. Moreover, several predictions
resulting from SMAP-WS have been validated experimentally. Thus far SMAP-WS has been applied to
predict drug side effects, and to repurpose existing
drugs for new indications. SMAP-WS provides both a
user-friendly web interface and programming API for
scientists to address a wide range of compute
intense questions in biology and drug discovery.
AVAILABILITY
SMAP-WS is available from the URL http://smap
.nbcr.net.
INTRODUCTION
The 3D structure of a protein is an essential component in
elucidating biological function(s) at the molecular level.
Ligand-binding sites and their interactions with binding
partners provides a strong correlation between structure
and function and thus are critical to address a wide range
of fundamental and practical problems—predicting functions for structural genomics targets, bridging knowledge
derived from small molecules and proteins, correlating molecular functions to physiological processes, studying
protein evolution and diversity, and designing safe and efﬁcient therapeutics.
The SMAP web service (SMAP-WS) is distinct from
the downloadable software and is designed for web accessible 3D ligand-binding site comparison and similarity
searching on a structural proteome scale. The underlying
algorithms comprising SMAP-WS and the standalone
software, SMAP, are distinct from existing web servers
SiteEngine (1), SitesBase (2,3), CavBase (4–6), SuMo (7),
PdbSiteScan (8), eF-Site (9,10), pvSOAR (11), ProFunc
(12), PevoSoar (13) and fPOP(14). First, SMAP represents
protein structures using C-a atoms only and hence is
tolerant to structural variation, meaning it can be
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applied to homology models and low-resolution structures. Second, amino acid residues are characterized by
surface orientation and a geometric potential (15) which
provides a geometrical constraint to reduce the search
space when undertaking ligand-binding site comparison.
Third, two structures are compared using a sequence order
independent proﬁle–proﬁle alignment (SOIPPA) algorithm (16). SOIPPA aligns two structures in the spirit of
local sequence alignment, but independent of the sequence
order. As a result the location and boundary of the
ligand-binding site does not need to be pre-deﬁned. This
property is important for real world applications since
information on the ligand-binding site may be unknown.
Fourth, SMAP can compare two biological units that may
include multiple chains. This is important since binding
sites may be located in the homo- or hetero-dimer interface. For example, the binding site of the antibiotic
myxopyronin to the bacterial RNA polymerase is
located in the ‘switch region’ between the b and b0
chains. Finally, SMAP determines the similarity between
two binding sites through the combination of geometrical
ﬁt, residue conservation and physiochemical similarity.
The statistical signiﬁcance of the similarity is estimated
using an extreme value distribution model (17). Putting
these features together within a parallel computing environment means that SMAP-WS is capable of an all-by-all
comparison of binding sites for a complete structural
proteome.
In benchmark studies, SOIPPA outperforms most
existing ligand-binding site comparison algorithms (16).
Around 30% of evolutionary and functional relationships across superfamilies are identiﬁed by SOIPPA with
a false–positive ratio of 5%. Moreover, SOIPPA outperforms global structural alignment algorithms in detecting
remote homologous that belong to the same superfamily.
For a false–positive ratio of 5%, SOIPPA detects 15%
more true positives than the global structural alignment.
More important, several predictions from SMAP have
been experimentally validated (16,18–20). Given the reliability of SMAP, it has been applied to constructing drug–
target interaction networks on a structural proteome scale
(17), predicting molecular mechanisms of drug side eﬀects
(21,22), repurposing old drugs for new medical usage (19),
designing polypharmacology (dirty) drugs (18), and establishing evolutionary relationships across protein fold
space (16). Thus, SMAP is useful for studying fundamental questions in protein structure, function and evolution,
as well as for computer aided drug design based on
polypharmacology. As standalone software, SMAP can
be installed locally and executed from the command line.
SMAP-WS has several improvements that make it more
user-friendly and computationally eﬃcient. SMAP-WS
has a web-based interface for the input of PDB structures,
the set of required parameters, a Jmol visualization plugin
to analyze results, pre-computed databases to search
against and a parallel implementation of SMAP accessible
from a large compute cluster to improve database search
speed. Thus SMAP-WS facilitates the application of comparative ligand-binding site analysis to address practical
problems in biology and drug discovery.

METHODS
Opal powered SMAP web services
SMAP-WS is powered by Opal (23), a toolkit that enables
scientists to easily wrap applications as web services that
have user-friendly web forms by conﬁguring simple
XML ﬁles. Two SMAP-WS interfaces are implemented:
(i) pair-wise comparison of two potential ligand-binding
sites; and (ii) search using a query structure against a
non-redundant structure database from the RCSB
Protein Data Bank (PDB) (24). In the ﬁrst application
structures and their components can be chosen from the
PDB or uploaded by the user. In the second application
the user may either choose to enter a PDB structure id and
its chain id(s) or upload a structure ﬁle in PDB format.
The user can then choose to perform a search using this
structure against several databases, including human homologous proteins and non-redundant PDB structures
based on sequence identities of 30 and 90%, respectively.
The user has the option to modify the appropriate
SMAP-WS parameters for both applications. In order to
improve the search speed, the database search has
pre-cached the protein structures used for the SMAP comparison. The structure cached is characterized by geometric, evolutionary and physiochemical properties and uses
default parameters. The pair-wise comparison interface
provides the user with the ability to modify more parameters for comparing two protein structures based on the
similarity of their potential ligand-binding sites.
In additional to the web input forms (http://smap.ncbr
.net), SMAP-WS can be accessed through a programming
API. The details of how to write a client program can be
found on the web site.
Output of SMAP-WS
The hits from a database search are sorted by the similarity score of the match, along with P-values of the match,
their PDB structure ids, chain ids and biological descriptions. The PDB id is linked to the structure summary page
of the RCSB PDB (http://www.rcsb.org/pdb). For each
of the hits, detailed information on the ligand-binding
site similarity is presented (P-value, raw alignment
score, RMSD and Tanimoto coeﬃcient of overlap). The
amino-acid residue alignment between two ligand-binding
sites and the transformation matrix to superpose them are
also displayed.
It is important to evaluate if the predicted residue
cluster is a potential binding region. SMAP-WS relies on
the geometric potential (15), which is a shape descriptor to
characterize both local and global topological properties
of each residue, to determine whether a residue is located
in a pocket on the protein structure or not. However, in a
real application where the binding region is unknown,
additional information such as ligand-binding aﬃnity
may be required to determine if the predicted region is
suited for ligand binding. Thus, a visualization tool that
allows the user to inspect the protein–ligand complex
structure was implemented. A Jmol plugin (Jmol: an
open-source Java viewer for chemical structures in 3D.)
that displays the superposition of two protein structures
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benchmark test, 6.5 and 25.9% of predicted binding
poses fall within RMSD values of <2.0 and <5.0 Å, respectively, when compared with co-crystallized ligands
that bind to proteins with diﬀerent folds. Hence, the predicted protein–ligand complex from SMAP-WS could be
used as a starting point for more computational intensive
studies. The pipeline has been successfully applied to determine the polypharmacological targets of Trypanosoma
Brucei RNA-ligase inhibitors (18). To facilitate such applications, SMAP-WS allows users to download the structure of potential oﬀ-targets with the superposed ligand.
These complexes can then be subject to more computationally intensive studies such as protein–ligand docking
and MD simulation.
Paralleled implementation of SMAP-WS
Figure 1. Two superposed structures of steroid delta-isomerase
(PDB id: 1OHP, blue backbone) and estrogen receptor ligand-binding
domain (PDB id 1QKT, red backbone) from an SMAP alignment. The
co-crystalized estradiol in 1QKT is shown as a light blue stick model.
The aligned residues between the two structures are highlighted.

with predicted and aligned ligand-binding site residues
is provided. An example of such a superposition is
shown in Figure 1. The estrogen receptor ligand-binding
domain (PDB id: 1QKT) is compared with the steroid
delta-isomerase (PDB id: 1OHP) without specifying the
co-crystallized ligand-binding site (in the web interface,
the option of ‘search only co-crystal ligand sites’ for
both structures was set to false). A statistically signiﬁcant
similarity between the two estradiol ligand-binding sites is
detected (P = 4.09e–6), although the two structures do not
share global structure or sequence similarity [FATCAT
(25) P-value 1.19e–1, and sequence identity %9.62], and
the estradiol-binding sites are not pre-deﬁned in both of
the structures.
One of the major applications of SMAP is to predict
oﬀ-targets given a known protein–ligand complex. The
ligand-binding site similarity between two proteins alone
is prerequisite, but not suﬃcient to determine their
cross-reactivity for a speciﬁc ligand. The chemical nature
of the ligand also contributes to the binding promiscuity.
For example, staurosporine can bind to a large panel of
kinases with Kd < 100 nm. However, compound VX-745 is
a highly speciﬁc ATP competitive inhibitor of p38 MAP
kinase (26). A more recent case is the chemical phylogenetic study of histone deacetylases (HDAC), where two
chemical analogs have diﬀerent binding proﬁles across
multiple members of the HDAC superfamily (27). To
computationally determine the potential oﬀ-target
binding, it is necessary to calculate the binding free
energy of the protein–ligand complex using techniques
such as protein–ligand docking and molecular dynamics
simulation. SMAP-WS narrows down the potential oﬀtargets to a small subset of the whole structure proteome
as well as provides an initial binding pose for the given
ligand to the oﬀ-target it found in the query structure. The
accuracy of predicted binding poses by SMAP-WS has
been evaluated in a previous study (16). In a rigorous

SMAP-WS database search is scheduled by the Sun Grid
Engine (SGE), which allows SMAP pair-wise comparison
to be executed concurrently on all available compute
nodes. As a result, SMAP-WS signiﬁcantly improves the
speed of ligand-binding site database searching. Using
SMAP on a single processor, sequential comparison of a
query structure against a database of about 40 000
non-redundant structures from the PDB takes more than
20 days (17). Our solution to speed up this process was to
set up a wrapper program that submits a SGE array job
for the set of SMAP comparisons to allow these comparisons to run in parallel on the computer nodes in a cluster.
The SMAP-WS server cluster has available up to 99
computer nodes with two processors on each node. Thus
198 SMAP-WS jobs can run in parallel, when all computer
nodes are available, with a scan of the non-redundant
PDB being done within one day.
CONCLUSION
We have developed a high performance computation
environment SMAP-WS for protein ligand-binding site
comparison and database searching. SMAP-WS provides
both user-friendly interfaces and a programming API to
help a wide spectrum of scientists to access the service. It is
expected that the integration of SMAP-WS with other
bioinformatics, molecular modeling and systems biology
tools will facilitate the study of protein–ligand interactions
on a structural proteome scale and drug design based on
polypharmacology.
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